Emerging from the UK, retatrutide, a innovative compound , is creating considerable excitement within the medical community regarding its ability for body regulation. This dual GIP and GLP-1 receptor agonist looks to deliver a substantial benefit over current therapies, showing promising results in initial clinical studies . Researchers suggest its